may escalate to 1 mg or 2 mg weekly based on glycaemic response For oral semaglutide (Rybelsus) used in type 2 diabetes: Starting dose: 3 mg once daily for 30 days Increase to 7 mg once daily
Lecithin, phosphatidylcholine and choline - Learn more about the potential link between them and cardiovascular disease
Below is a list of some of the medications you may be familiar with and their TGA approved indications 1 : Benefits, Risks and Side-Effects of GLP-1 Therapy Evidence-based Benefits of GLP-1 Therapy Glycaemic (blood sugar) management In people with type 2 diabetes, GLP-1 RAs significantly reduce HbA1c levels (often by 0.51.5 %) and reduce the occurrence of hyperglycaemic spikes
Conditions such as vitamin deficiencies, medication interactions, or unrelated oral or neurological conditions can cause taste disturbances and should be considered in the differential diagnosis
First developed in the early 2000s to treat type 2 diabetes by mimicking the action of the naturally occurring hormone glucagon-like peptide 1, GLP-1 receptor agonists have since been shown to have a positive and significant impact on obesity, other medical conditions and biological functions
